Esomeprazole Market (Dosage Type - Tablets, Capsules, and Others; Application - Gastroesophageal Reflux Disease, Duodenal Ulcer, Efficacy, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027

A recent report ongoing study by Infinium Global Research on the esomeprazole market provides an in-depth analysis of segments and sub-segments in the global as well as regional esomeprazole market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional esomeprazole market over the short term as well as the long term. The report is a comprehensive presentation of trends, forecasts, and dollar values of the global esomeprazole market. According to the report, the global esomeprazole market is projected to grow at a significant CAGR over the forecast period of 2021-2027. 

Market Insight

The esomeprazole is administrated in the magnesium salt form, and it is a compound of an isomer of omeprazole. Esomeprazole is used to treat esophagitis, gastroesophageal reflux disease, and peptic ulcer reduces stomach acid and Zollinger–Ellison syndrome and is sold under the name of Nexium. Furthermore, the esomeprazole is administrated in the patient’s body either orally or injected directly into the vein. However, esomeprazole has many side effects like headache, constipation, dry mouth, and abdominal pain, and some severe side effects are angioedema, pneumonia, and Clostridium infection. Moreover, esomeprazole is also very useful in pregnancy since it is used for a safe pregnancy and for breastfeeding. Additionally, esomeprazole mainly works for overall benefits in esophageal and symptom relief. Due to the mortification of the drug in acidic conditions of the stomach, the esomeprazole capsule is coated with barrier polymer, and it is done by using the multiple-unit pellet system; this tablet is also known as the "multiple-unit pellet system" (MUPS). Furthermore, esomeprazole capsule when treated with an aqueous solution, then water enters the capsule by osmosis, and the contents of the capsule get absorbed into the human body due to the breakage of the shell. 

Increasing the use of esomeprazole to treat the symptoms of heartburn and disorders that involve excessive stomach acids results in increased demand for the medicine. This is the prime factor propelling the growth of the esomeprazole market. Furthermore, these drugs have low treatment costs and are sold without any prescriptions; hence there is enormous demand for such drugs in the market. Moreover, easy availability and overall decreased cost are other factors driving the growth of the esomeprazole market. The other factors driving the market’s growth are the increase in the adoption of drug delivery systems and the successful launch of new products. While the increase in the intensity of GERD (Gastroesophageal reflux disease), which is a hazardous disorder, becomes a significant factor that boosts the market’s growth. However, the minor side effects of the esomeprazole drugs like nausea, headaches, dry mouth, diarrhea, and significant side effects like kidney disease and dementia are anticipated to hamper the growth of the esomeprazole market during the forecast period. Nevertheless, rising developments in the healthcare sector and increasing awareness of medicine give the esomeprazole market an exponential growth opportunity.

Due to the rising geriatric population and the increasing presence of product approvals. There is a high risk of developing gastrointestinal diseases such as gastroesophageal reflux disease in older people. The U.S. Census Bureau, in 2018, stated that around 52 million more aging population was living in the United States; hence the North American region is projected to witness the highest growth in the esomeprazole market. Furtherer, Asia Pacific is projected to be the fastest-growing market over the forecast period due to increasing prevalence rate, increasing focus on preventive care, and government initiatives promoting technological innovations. For instance, a study conducted by Takeda's (Millennium Pharmaceuticals, Inc.) states that the effect of the proton pump inhibitor (PPI) esomeprazole on the single-dose PK of orally administered TAK-906 under Phase 1 trials, due to which there will be high demand for the esomeprazole in the region. 

Segment Covered

The report on the global esomeprazole market covers segments such as dosage type, and application. On the basis of dosage type, the sub-markets include tablets, capsules, and others. On the basis of application, the sub-markets include gastroesophageal reflux disease, duodenal ulcer, efficacy, and others. 

Companies Profiled:

The report provides profiles of the companies in the market such as Daiichi Sankyo, Astrazeneca PLC, Zydus Pharmaceuticals Inc., Sun Pharmaceutical Industries Inc., Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Dr. Reddy's Laboratories Inc., Torrent Pharma Inc., Amneal Pharmaceuticals LLC, and Glenmark Pharmaceuticals. 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the esomeprazole market. Moreover, the study highlights current market trends and provides forecasts from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.